FREE Account Opening + No Clearing Fees
Loading...

Empyrean Cashews IPO vs Evoq Remedies IPO

Comparision between Empyrean Cashews IPO and Evoq Remedies IPO.

IPO Details

Empyrean Cashews IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Evoq Remedies IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  Empyrean Cashews IPO Evoq Remedies IPO
Logo Empyrean Cashews IPO Logo Evoq Remedies IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At NSE SME BSE SME
Lead Managers Systematix Corporate Services Limited Swastika Investmart Ltd
Registrar Purva Sharegistry India Pvt Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Empyrean Cashews IPO is up to ₹19.41 Cr whereas the issue size of the Evoq Remedies IPO is up to ₹9.72 Cr. The final issue price of Empyrean Cashews IPO is ₹37.00 per share and of Evoq Remedies IPO is ₹27.00 per share.

  Empyrean Cashews IPO Evoq Remedies IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹37.00 per share ₹27.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 3000 shares 4000 shares
Fresh Issue Size 52,47,000 shares 36,00,000 shares
Fresh Issue Size (Amount) up to ₹19.41 Cr up to ₹9.72 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 52,47,000 shares 36,00,000 shares
Issue Size Total (Amount) up to ₹19.41 Cr up to ₹9.72 Cr

IPO Timetable

Empyrean Cashews IPO opens on Mar 21, 2022, while Evoq Remedies IPO opens on Mar 17, 2022. The closing date of Empyrean Cashews IPO and Evoq Remedies IPO is Mar 23, 2022, and Mar 22, 2022, respectively.

  Empyrean Cashews IPO Evoq Remedies IPO
Anchor Bid Date
Issue Open Mar 21, 2022 Mar 17, 2022
Issue Close Mar 23, 2022 Mar 22, 2022
Basis Of Allotment (Tentative) Mar 28, 2022 Mar 25, 2022
Initiation of Refunds (Tentative) Mar 30, 2022 Mar 28, 2022
Credit of Share (Tentative) Mar 30, 2022 Mar 29, 2022
Listing date (Tentative) Mar 31, 2022 Mar 30, 2022
Anchor Lockin End date 1 Apr 27, 2022 Apr 24, 2022
Anchor Lockin End date 2 Jun 26, 2022 Jun 23, 2022

Financials

Empyrean Cashews IPO P/E ratio is 25.69, as compared to Evoq Remedies IPO P/E ratio of 33.75.

  Empyrean Cashews IPO Evoq Remedies IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in Lakhs)
  31-Oct-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,191.20 2,156.19 1,641.48 1,610.58
Total Revenue 2,722.71 2,858.08 4,438.69 5,047.27
Profit After Tax 166.69 66.74 95.60 64.95
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in Lakh)
  10-Feb-22 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2660.58 804.63 565.22 214.78
Total Revenue 1056.58 1002.48 907.21 325
Profit After Tax 93.67 71.38 0.03 1.11
Promoter Shareholding (Pre-Issue) 56.99% 99.99%
Promoter Shareholding (Post-Issue) 41.88% 73.53%
P/E Ratio 25.69 33.75
Market Cap ₹73.24 Cr. ₹36.72 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Empyrean Cashews IPO retail investors (RII) are offered 24,91,500 shares while in Evoq Remedies IPO retail investors are offered 24,91,500 shares. Qualified institutional buyers (QIB) are offered in Empyrean Cashews IPO and in Evoq Remedies IPO.

  Empyrean Cashews IPO Evoq Remedies IPO
Anchor Investor Reserveration
Market Maker Reserveration 2,64,000 shares 1,80,000 shares
QIB
NII 24,91,500 shares 17,10,000 shares
RII 24,91,500 shares 17,10,000 shares
Employee
Others
Total 49,83,000 shares 34,20,000 shares

Bids Received (Subscription)

Empyrean Cashews IPO subscribed 2.28x in total, whereas Evoq Remedies IPO subscribed 1.67x.

  Empyrean Cashews IPO Evoq Remedies IPO
QIB (times)
NII (times) 2.92x 0.30x
Big NII (times)
Small NII (times)
RII (times) 1.63x 3.03x
Employee (times)
Other (times)
Total (times) 2.28x 1.67x

Comments

Add a public comment...